Zmks International Cancer Therapy Biotechnologies is Biotechnology in China that focus on gene therapy techniques business. Founded in 2008. They cover business area such as develop, manufacturer, cancer treatment technology, equipment, cancer stem cell technology, tumor immune cell therapy, gene therapy technique, molecular target cancer therapy, patient, immediate ailment.
2008
( 16 years old in 2024 )
Gene Therapy Techniques
-
Shenzhen
China
Private
developmanufacturercancer treatment technologyequipmentcancer stem cell technologytumor immune cell therapygene therapy techniquemolecular target cancer therapypatientimmediate ailment
* We use standard office opening hours in near Zmks International Cancer Therapy Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Zmks International Cancer Therapy Biotechnologies is Biotechnology business from China that founded in 2008 (16 years old in 2024), Zmks International Cancer Therapy Biotechnologies business is focusing on Gene Therapy Techniques.
Zmks International Cancer Therapy Biotechnologies headquarter office and corporate office address is located in Shenzhen China.
Zmks International Cancer Therapy Biotechnologies was founded in China.
In 2024, Zmks International Cancer Therapy Biotechnologies is currently focus on gene therapy techniques sector.
Above is snippet of Google Trends for "gene therapy techniques" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Zmks International Cancer Therapy Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
